March 27th, 2014 - Volume 97 - Issue 6
pp: 603-714,e33-e38


Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients

Brokhof, Marissa M.; Sollinger, Hans W.; Hager, David R.; More

Transplantation. 97(6):612-617, March 27th, 2014.

Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

Silva, Hélio Tedesco Jr; Yang, Harold C.; Meier-Kriesche, Herwig-Ulf; More

Transplantation. 97(6):636-641, March 27th, 2014.

Preformed Donor-Specific Antibodies and Risk of Antibody-Mediated Rejection in Repeat Renal Transplantation

Tsapepas, Demetra S.; Vasilescu, Rodica; Tanriover, Bekir; More

Transplantation. 97(6):642-647, March 27th, 2014.

Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients

Deng, Mario C.; Elashoff, Barbara; Pham, Michael X.; More

Transplantation. 97(6):708-714, March 27th, 2014.

1 2 3 4 5